+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Schizophrenia Drugs Market Research Reports

From
Schizoaffective Disorder - Pipeline Insight, 2021 - Product Thumbnail Image

Schizoaffective Disorder - Pipeline Insight, 2021

  • Clinical Trials
  • September 2021
  • 60 Pages
From
From
From
Schizophrenia - Pipeline Insight, 2021 - Product Thumbnail Image

Schizophrenia - Pipeline Insight, 2021

  • Clinical Trials
  • July 2021
  • 120 Pages
From
Disease Analysis: Schizophrenia - Product Thumbnail Image

Disease Analysis: Schizophrenia

  • Report
  • March 2021
  • 101 Pages
From
Schizophrenia - Competitive Landscape in 2020 - Product Thumbnail Image

Schizophrenia - Competitive Landscape in 2020

  • Report
  • November 2020
  • 61 Pages
From
Schizophrenia - Pipeline Review, H2 2020 - Product Thumbnail Image

Schizophrenia - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 440 Pages
From
From
US Schizophrenia Drugs Market 2020-2026 - Product Thumbnail Image

US Schizophrenia Drugs Market 2020-2026

  • Report
  • September 2020
From
UK Schizophrenia Drugs Market 2020-2026 - Product Thumbnail Image

UK Schizophrenia Drugs Market 2020-2026

  • Report
  • September 2020
From
From
From
From
From
From
Loading Indicator

The Schizophrenia Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of medications used to treat schizophrenia. Schizophrenia is a mental disorder characterized by abnormal social behavior and failure to recognize what is real. Common symptoms include delusions, hallucinations, disorganized speech, and disorganized behavior. The Schizophrenia Drugs market is composed of a variety of companies, including large pharmaceutical companies, small biotech firms, and generic drug manufacturers. These companies develop and market medications that are used to treat schizophrenia, such as antipsychotics, antidepressants, and mood stabilizers. Many of these medications are available in both generic and brand-name forms. Some of the major companies in the Schizophrenia Drugs market include Johnson & Johnson, Pfizer, Eli Lilly, Novartis, and AstraZeneca. These companies have developed a range of medications to treat schizophrenia, including Abilify, Seroquel, Zyprexa, and Risperdal. Show Less Read more